Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 6
2004 7
2005 8
2006 7
2007 8
2008 10
2009 7
2010 2
2011 6
2012 6
2013 2
2014 5
2015 2
2016 2
2017 4
2018 3
2019 2
2020 11
2021 2
2022 3
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Results by year

Filters applied: . Clear all
Page 1
Reply.
Miller V, Harrington P, Howe A, Kieffer T, Lennerstrand J, Lenz O, Lontok E, McPhee F, Mo H, Parkin N, Pilot-Matias T. Miller V, et al. Among authors: parkin n. Hepatology. 2016 Aug;64(2):698-9. doi: 10.1002/hep.28615. Epub 2016 May 27. Hepatology. 2016. PMID: 27113118 No abstract available.
Checklist for studies of HIV drug resistance prevalence or incidence: rationale and recommended use.
Mbuagbaw L, Garcia C, Brenner B, Cecchini D, Chakroun M, Djiadeu P, Holguin A, Mor O, Parkin N, Santoro MM, Ávila-Ríos S, Fokam J, Phillips A, Shafer RW, Jordan MR. Mbuagbaw L, et al. Among authors: parkin n. Lancet HIV. 2023 Oct;10(10):e684-e689. doi: 10.1016/S2352-3018(23)00173-X. Epub 2023 Sep 13. Lancet HIV. 2023. PMID: 37716367 Free PMC article. Review.
Clinical Impact of Pretreatment Human Immunodeficiency Virus Drug Resistance in People Initiating Nonnucleoside Reverse Transcriptase Inhibitor-Containing Antiretroviral Therapy: A Systematic Review and Meta-analysis.
Bertagnolio S, Hermans L, Jordan MR, Avila-Rios S, Iwuji C, Derache A, Delaporte E, Wensing A, Aves T, Borhan ASM, Leenus A, Parkin N, Doherty M, Inzaule S, Mbuagbaw L. Bertagnolio S, et al. Among authors: parkin n. J Infect Dis. 2021 Aug 2;224(3):377-388. doi: 10.1093/infdis/jiaa683. J Infect Dis. 2021. PMID: 33202025 Free PMC article. Review.
Sequence and phenotypic analysis for resistance monitoring in hepatitis C virus drug development: recommendations from the HCV DRAG.
Kwong AD, Najera I, Bechtel J, Bowden S, Fitzgibbon J, Harrington P, Kempf D, Kieffer TL, Koletzki D, Kukolj G, Lim S, Pilot-Matias T, Lin K, Mani N, Mo H, O'Rear J, Otto M, Parkin N, Pawlotsky JM, Petropoulos C, Picchio G, Ralston R, Reeves JD, Schooley RT, Seiwert S, Standring D, Stuyver L, Sullivan J, Miller V; Forum for Collaborative Human Immunodeficiency Virus Research; HCV Drug Development Advisory Group (HCV DRAG); Sequence Analysis Working Group (SAWG); Phenotype Analysis Working Group (PAWG). Kwong AD, et al. Among authors: parkin n. Gastroenterology. 2011 Mar;140(3):755-60. doi: 10.1053/j.gastro.2011.01.029. Epub 2011 Jan 19. Gastroenterology. 2011. PMID: 21255574 No abstract available.
104 results